IFNGR2 and neoplasm: To investigate whether IFN-γ-insensitive tumor cells showed decreased expression of a negative immune regulatory factor, RNASeq was performed on purified tumor cells from WT, IFNγR2-, and Jak1-mutant tumors on day 7 after tumor engraftment.